Egetis Therapeutics AB (publ) (EGTX) — Tangible Net Worth Ratio
Egetis Therapeutics AB (publ) (EGTX) has a Tangible Net Worth Ratio of -45.9% as of March 2026. This metric is calculated by deducting intangible assets (Skr362.90 Million) from net assets (Skr248.70 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Egetis Therapeutics AB (publ) (EGTX) equity growth momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Egetis Therapeutics AB (publ) Tangible Net Worth Ratio (2008–2025)
This chart shows how Egetis Therapeutics AB (publ)'s Tangible Net Worth Ratio has changed across 18 annual periods from 2008 to 2025. As of March 2026, the ratio stands at -45.9%, reflecting net assets of Skr248.70 Million with intangible assets of Skr362.90 Million SEK. For live market cap and overall valuation, see EGTX company net worth.
Annual Tangible Net Worth Ratio for Egetis Therapeutics AB (publ) (2008–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Egetis Therapeutics AB (publ) from 2008 to 2025, covering 18 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Egetis Therapeutics AB (publ) capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -10.2% | Skr338.70 Million | Skr373.30 Million | Skr639.10 Million | ▼ -27.4 pp |
| 2024 | 17.2% | Skr492.90 Million | Skr408.00 Million | Skr792.30 Million | ▼ -7.8 pp |
| 2023 | 25.0% | Skr545.60 Million | Skr409.10 Million | Skr760.20 Million | ▲ +6.1 pp |
| 2022 | 18.9% | Skr506.20 Million | Skr410.30 Million | Skr561.10 Million | ▼ -3.0 pp |
| 2021 | 22.0% | Skr527.04 Million | Skr411.31 Million | Skr569.27 Million | ▲ +15.6 pp |
| 2020 | 6.4% | Skr629.63 Million | Skr589.36 Million | Skr893.97 Million | ▼ -93.6 pp |
| 2019 | 100.0% | Skr244.88 Million | Skr0.00 | Skr270.07 Million | ▲ +0.0 pp |
| 2018 | 100.0% | Skr219.36 Million | Skr0.00 | Skr242.04 Million | ▲ +0.0 pp |
| 2017 | 100.0% | Skr303.71 Million | Skr0.00 | Skr315.37 Million | ▲ +0.0 pp |
| 2016 | 100.0% | Skr389.56 Million | Skr0.00 | Skr396.44 Million | ▲ +0.0 pp |
| 2015 | 100.0% | Skr48.03 Million | Skr0.00 | Skr52.36 Million | ▲ +0.0 pp |
| 2014 | 100.0% | Skr90.66 Million | Skr0.00 | Skr103.47 Million | ▲ +0.0 pp |
| 2013 | 100.0% | Skr46.95 Million | Skr0.00 | Skr51.01 Million | ▲ +0.0 pp |
| 2012 | 100.0% | Skr53.94 Million | Skr0.00 | Skr60.46 Million | ▲ +0.0 pp |
| 2011 | 100.0% | Skr87.53 Million | Skr0.00 | Skr91.42 Million | ▲ +110.0 pp |
| 2010 | -10.0% | Skr6.99 Million | Skr7.69 Million | Skr8.49 Million | ▼ -108.6 pp |
| 2009 | 98.6% | Skr5.64 Million | Skr79.46K | Skr5.91 Million | ▼ -1.4 pp |
| 2008 | 100.0% | Skr5.05 Million | Skr0.00 | Skr5.37 Million | — |